00-382. Golden American Life Insurance Company, et al.; Notice of Application  

  • [Federal Register Volume 65, Number 5 (Friday, January 7, 2000)]
    [Notices]
    [Pages 1192-1195]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 00-382]
    
    
    -----------------------------------------------------------------------
    
    SECURITIES AND EXCHANGE COMMISSION
    
    [Rel. No. IC-24228; File No. 812-11748]
    
    
    Golden American Life Insurance Company, et al.; Notice of 
    Application
    
    December 30, 1999.
    AGENCY: Securities and Exchange Commission (``SEC or ``Commission'').
    
    ACTION: Notice of application for an order of approval pursuant to 
    Section 26(b) of the Investment Company Act of 1940 (``Act'').
    
    -----------------------------------------------------------------------
    
    SUMMARY OF APPLICATION: Applicants seek an order pursuant to Section 
    26(b) of the Act, approving the substitution of shares of the Mid-Cap 
    Growth Series of The GCG Trust for shares of the Growth Opportunities 
    Series of The GCG Trust.
    
    APPLICANTS: Golden American Life Insurance Company (``Golden 
    American''), Golden American Life Insurance Company Separate Account A 
    (``Golden American Separate Account A''), Golden American Life 
    Insurance Company Separate Account B (``Golden American Separate 
    Account B''), Equitable Life Insurance Company of Iowa (``Equitable''), 
    Equitable Life Insurance Company of Iowa Separate Account A 
    (``Equitable Separate Account A''), First Golden American Life 
    Insurance Company of New York (``First Golden''), and First Golden 
    American Life Insurance Company of New York Separate Account NY-B 
    (``First Golden Separate Account NY-B'').
    
    FILING DATES: The application was filed on August 13, 1999, and amended 
    and restated on December 23, 1999.
    
    HEARING OR NOTIFICATION OF HEARING: An order granting the application 
    will be issued unless the SEC orders a hearing. Interested persons may 
    request a hearing by writing the Secretary of the SEC and serving 
    Applicants with a copy of the request, in person or by mail. Hearing 
    requests should be received by the SEC by 5:30 p.m. on January 24, 
    2000, and should be accompanied by proof of service on Applicants, in 
    the form of an affidavit or, for lawyers, a certificate of service. 
    Hearing requests should state the nature of the writer's interest, the 
    reason for the request, and the issues contested. Persons who wish to 
    be notified of a hearing may request notification of a hearing by 
    writing to the Secretary of the SEC.
    
    ADDRESSES: Secretary, SEC, 450 Fifth Street, NW, Washington, DC 20549-
    0609. Applicants, Marilyn Talman, Esquire, Golden American Life 
    Insurance Company, 1475 Dunwoody Drive, West Chester, Pennsylvania 
    19380.
    
    FOR FURTHER INFORMATION CONTACT: Ronald A. Holinsky, Attorney, or Susan 
    M. Olson, Branch Chief, Office of Insurance Products, Division of 
    Investment Management, at (202) 942-0670.
    
    SUPPLEMENTARY INFORMATION: The following is a summary of the 
    application. The complete application is available for a fee from the 
    Public Reference Branch of the SEC, 450 Fifth Street, NW, Washington, 
    DC 20549-0102, or call (202) 942-8090.
    
    Applicants' Representations
    
        1. Golden American and Equitable are stock life insurance companies 
    organized under the insurance laws of Delaware and Iowa, respectively. 
    Each is authorized to write variable annuity and variable life 
    insurance policies in at least 48 states and the District of Columbia. 
    First Golden is a stock life insurance company organized under the 
    insurance laws of the state of New York, and is authorized to write 
    variable annuity contracts in New York and Delaware. Golden American, 
    Equitable and First Golden (collectively, ``Applicant Insurance 
    Companies'') are wholly owned subsidiaries of ING Groep N.V. (``ING''), 
    a global financial services holding company.
        2. Equitable Separate Account A, Golden Separate Account A, Golden 
    Separate Account B and First Golden Separate Account NY-B 
    (collectively,
    
    [[Page 1193]]
    
    ``Applicant Separate Accounts'') are separate accounts for which one of 
    the Applicant Insurance Companies serves as the sponsor and depositor. 
    Golden American serves as sponsor and depositor of Golden Separate 
    Account A and Golden Separate Account B; Equitable serves as sponsor 
    and depositor of Equitable Separate Account A; First Golden serves as 
    sponsor and depositor of First Golden Separate Account NY-B. Each 
    Applicant Separate Account is a segregated asset account of its 
    insurance company sponsor and each is registered under the Act as a 
    unit investment trust. Each Applicant Separate Account is administered 
    and accounted for as part of the general business of the Applicant 
    Insurance Company of which it is a part. The income, gains or losses of 
    Applicant Separate Accounts are credited to or charged against the 
    assets of each such separate account, without regard to income, gains 
    or losses of such Applicant Insurance Company.
        3. Each Applicant Separate Account serves as a finding vehicle for 
    certain variable annuity and/or variable life contracts (collectively, 
    ``Variable Contracts'') written by the respective Applicant Insurance 
    Companies. Applicant Separate Accounts are divided into separate 
    subaccounts, each dedicated to owning shares of one of the investment 
    options available under the Variable Contracts. The Variable Contracts 
    are structured such that holders of any of the Variable Contracts 
    (``Contractholders'') may select one or more of the investment options 
    available under the contract held by allocating premiums payable under 
    such contract to that subaccount of the relevant Applicant Separate 
    Account that corresponds to the investment option desired. Thereafter, 
    Contractholders accumulate funds, on a tax-deferred basis, based on the 
    investment experience of the selected subaccount(s). Contractholders 
    may, during the life of the contract, make unlimited transfers of 
    accumulation values among the subaccounts available under the contract 
    held, subject to any applicable administrative and/or transfer fees.
        4. The GCG Trust is registered under the Act as an open-end, 
    management, series investment company. The GCG Trust offers shares of 
    several separate investment series, including the Growth Opportunities 
    Series and the Mid-Cap Growth Series.
        5. Under the terms of an investment advisory agreement (``Trust 
    Management Agreement'') between the GCG Trust and Directed Services, 
    Inc. (``DSI''), DSI manages the business and affairs of each of the 
    several series of the GCG Trust, subject to the control of the Board of 
    Trustees of the GCG Trust. Under the Trust Management Agreement, DSI is 
    authorized to exercise full investment discretion and make all 
    determinations with respect to the investment of the assets of the 
    respective series, but may, at its own cost and expense, retain 
    portfolio managers for the purpose of making investment decisions and 
    research information available to the GCG Trust. DSI has retained 
    Massachusetts Financial Services Company as portfolio manager of the 
    Mid-Cap Growth Series and Montgomery & Associates, Limited as portfolio 
    manager of the Growth Opportunities Series.
        6. Pursuant to the Trust Management Agreement, DSI is responsible 
    for providing the GCG Trust (or arranging and paying for the provision 
    to the GCG Trust) a comprehensive package of administrative and other 
    services necessary for the ordinary operation of certain selected 
    series of the Trust, including the Mid-Cap Growth Series and the Growth 
    Opportunities Series. This fee (``Unified Fee'') is calculated for the 
    participating GCG Trust series based on a percentage of assets basis 
    and in accordance with schedules that provide, for most of the GCG 
    Trust series, fee reductions at specified asset levels or ``break 
    points.'' One feature of the Unified Fee is that certain of the GCG 
    Trust series, which include the Mid-Cap Growth Series and the Growth 
    Opportunities Series, albeit in different groups, are grouped together 
    for the purpose of determining whether a break point has been reached. 
    The rate at which the Unified Fee payable to DSI is calculated will be 
    reduced when the combined assets of all of the GCG Trust series in the 
    designated fee group reach the scheduled break points. As a result, a 
    GCG Trust series that is part of a designated fee group is likely to 
    realize a reduction in the fee payable to DSI more quickly than might 
    otherwise be the case.
        7. The Variable Contracts expressly reserve to Applicant Insurance 
    Companies the right, subject to compliance with applicable law, to 
    substitute shares of another open-end management investment company for 
    shares of an open-end management investment company held by a sub-
    account of the appropriate Separate Account. The prospectuses for the 
    Variable Contracts and Applicant Separate Accounts contain appropriate 
    disclosure of this right.
        8. Applicant Insurance Companies propose to substitute shares of 
    the Mid-Cap Series for those of the Growth Opportunities Series 
    (``Substitution''). Following the Substitution, Applicant Separate 
    Accounts will have two subaccounts holding shares of the Mid-Cap Growth 
    Series and will combine these subaccounts.
        9. Applicants state that the investment objectives and policies of 
    the Mid-Cap Growth Series are sufficiently similar to those of the 
    Growth Opportunities Series to assure that the essential objectives and 
    risk expectations of those Contractholders with interest in the Growth 
    Opportunities Series subaccounts (``Affected Contractholders'') will be 
    met. Both the Mid-Cap Growth Series and the Growth Opportunity Series 
    share the primary objective of increase in value of the shares of the 
    portfolio securities (capital growth). The Mid-Cap Growth Series also 
    has the same investment strategy as the Growth Opportunities Series, of 
    allocating assets primarily among equity and bond classes of 
    investments, with the majority invested in equity investments in 
    companies with medium market capitalization. The Mid-Cap Growth Series 
    and the Growth Opportunities Series may invest up to 20% and 35%, 
    respectively, in foreign issuers. Both may also invest in over-the-
    counter securities. The chief distinction between the series is that 
    the Growth Opportunities Series is diversified and the Mid-Cap Growth 
    Series is non-diversified, although it is not currently taking 
    advantage of that distinction and has no present intention of doing so. 
    Applicants state that several factors could cause the Mid-Cap Growth 
    Series to change its investment style to non-diversified including a 
    response to extreme market conditions or a change of the portfolio 
    manager, although Applicants state that there is no desire to change 
    the portfolio manager. Golden American has, therefore, concluded that 
    the overall investment objectives of the Growth Opportunities Series 
    and the Mid-Cap Growth Series are sufficiently similar such that the 
    Mid-Cap Growth Series is appropriate for substitution.
        10. Applicants state that the lower expenses of the Mid-Cap Growth 
    Series was considered. The expense ratio for the nine-month period 
    ended September 30, 1999, for the Growth Opportunities Series and Mid-
    Cap Growth Series were 1.06% and 0.91%, respectively, and 1.15% and 
    0.95%, respectively for fiscal year 1998. Unified Fees as of September 
    30, 1999 based on net assets for that day for the Growth Opportunities 
    Series and Mid-Cap Growth Series were 1.03% and 0.90%, respectively.
    
    [[Page 1194]]
    
        11. Applicants also state that the better investment performance of 
    the Mid-Cap Growth Series was considered.
        12. Applicants state that the Substitution and the related 
    subaccount combinations are part of an overall business plan of 
    Applicant Insurance Companies to make their respective products, 
    including the Variable Contracts, more competitive and more efficient 
    to administer and oversee. Applicants represent that the Substitution 
    is appropriate because it will allow the GCP Trust to eliminate a 
    portfolio with poor performance and higher expenses and place 
    Contractholders in a position to participate in a portfolio with 
    better, more consistent performance and a lower Unified Fee.
        13. Applicants state that DSI serves as overall manager of the 
    Growth Opportunities Series and the Mid-Cap Growth Series. The 
    portfolio manager of the Mid-Cap Growth Series is Massachusetts 
    Financial Services Company. After the Substitution, Affected 
    Contractholders whose interest in the Growth Opportunities Series is 
    redeemed and invested in the Mid-Cap Growth Series will continue to 
    benefit from the services of DSI as overall manager.
        14. Applicants state that, as of the effective date of the 
    Substitution (`Effective Date''), shares of the Growth Opportunities 
    subaccounts of the Applicant Separate Accounts will be redeemed for 
    cash. Applicants, on behalf of the Growth Opportunities subaccounts of 
    Applicant Separate Accounts will simultaneously place a redemption 
    request with the Growth Opportunities Series and a purchase order with 
    the Mid-Cap Growth Series so that the purchase will be for the exact 
    amount of the redemption proceeds. The proceeds of such redemptions 
    will then be used to purchase the appropriate number of shares of the 
    Mid-Cap Growth Series. As a result, moneys attributable to 
    Contractholders currently invested in the Growth Opportunities Series 
    will be fully invested.
        15. The Substitution will take place at relative net asset value 
    (in accordance with Rule 22c-1 under the Act) with no change in the 
    amount of any Affected Contractholder's accumulation value of death 
    benefit or in the dollar value of his or her investment in the 
    Applicant Separate Accounts. Affected Contractholders will not incur 
    any fees or charges as a result of the proposed Substitution nor will 
    their rights or Applicant Insurance Companies' obligations under the 
    Variable Contracts be altered in any way. Applicant Insurance Companies 
    or their affiliates will pay all expenses incurred in connection with 
    the proposed Substitution, including legal, accounting, and other fees 
    and expenses. In addition, the proposed Substitution will not impose 
    any tax liability on Affected Contractholders. The proposed 
    Substitution will not cause the Variable contract fees and charges 
    currently being paid by Affected Contractholders to be greater after 
    the proposed Substitution than before the proposed Substitution. Also, 
    after notification of the Substitution, and for thirty days after the 
    Substitution, Affected Contractholders may reallocate, to any other 
    investment options available under their Variable Contract, their 
    Growth Opportunities subaccount accumulation value without incurring 
    any costs or excessive allocation charges.
        16. Immediately following the Substitution, Applicants will cause 
    the Growth Opportunities subaccounts of Applicant Separate Accounts to 
    combine with the Mid-Cap Growth subaccounts of Applicant Separate 
    Accounts at full net asset value so that there is no loss of account 
    value for the Contractholders. Affected Contractholders will not incur 
    any fees or charges as a result of this combination of subaccounts nor 
    will their rights or Applicants' obligations under the Variable 
    Contracts alter in any way. Applicants will pay all expenses incurred 
    in connection with the combinations, including legal and/or accounting 
    fees. In addition, the combination will no result in any adverse tax 
    liability on Affected Contractholders, or any change in the economic 
    interest or contract value of Affected Contractholders.
        17. Affected Contractholders were notified of the Application by 
    means of a supplement to the GCG Trust prospectus on or about August 
    30, 1999. Following the issuance of the requested order, but prior to 
    the Effective Date, each Affected Contractholder will receive a notice 
    setting forth the Effective Date and advising Affected Contractholders 
    of their right, if they so chose, at any time prior to the Effective 
    Date, to reallocate or withdraw accumulated value in the Growth 
    Opportunities subaccount under their Variable Contract or otherwise 
    terminate their interest thereof in accordance with the terms and 
    conditions of their Variable Contract. If Affected Contractholders 
    reallocate accumulation value prior tot he Effective Date or thirty 
    days after the Effective Date, there will be no charge for the 
    reallocation and it will not be counted toward the total number of 
    reallocations made within the contract year. All current 
    Contractholders have received a prospectus containing a description of 
    the Mid-Cap Growth Series and another copy will be forwarded to any 
    contractholder who requests one. Within five days after the Effective 
    Date, Affected Contractholders will receive a notice (``Substitution 
    Notice'') stating that shares of the Growth Opportunities Series have 
    been redeemed and that the shares of the Mid-Cap Growth Series have 
    been substituted. The Substitution Notice will include a written 
    confirmation showing the before and after accumulation values (which 
    will not have changed as a result of the substitution) and detailing 
    the transactions effected on behalf of the Affected Contractholder with 
    regard to the Substitution.
    
    Applicants' Legal Analysis
    
        1. Section 26(b) of the Act prohibits any depositor or trustee of a 
    unit investment trust that invests exclusively in the securities of a 
    single issuer from substituting the securities of another issuer 
    without the approval of the Commission. Section 26(b) provides that 
    such approval shall be granted by order of the Commission, if the 
    evidence establishes that the substitution is consistent with the 
    protection of investors and the purposes of the Act.
        2. Applicants request an order pursuant to Section 26(b) of the Act 
    approving the Substitution and related transactions. Applicants assert 
    that the purposes, terms, and conditions, of the proposed Substitution 
    and related transactions are consistent with the protection of 
    investors and the purposes fairly intended by the Act. Applicants 
    further assert that the Substitution will not result in the type of 
    costly forced redemption against which Section 26(b) was intended to 
    guard.
        3. Applicants represent that the terms of the redemptions and 
    purchases are reasonable and fair and do not involve overreaching on 
    the part of any person concerned and that the interest of 
    Contractholders will not be diluted. The redemptions and purchases will 
    be done at values consistent with the policies of both the Growth 
    Opportunities Series and the Mid-Cap Growth Series. Applicant Insurance 
    Companies and DSI will review all the asset transfers to assure that 
    the assets meet the objectives of the Mid-Cap Growth Series and that 
    they are valued under the appropriate valuation procedures of the 
    Growth Opportunities Series and the Mid-Cap Growth Series.
        4. Applicants represent that the combination of the Mid-Cap Growth
    
    [[Page 1195]]
    
    Series and the Growth Opportunities Series subaccounts in the manner 
    set forth in the Application is intended to reduce expenses and raise 
    investment return and thereby benefit Contractholders with assets in 
    those subaccounts. Thhe purchase and sale transactions described in the 
    Application will be effected based on the net asset value of the 
    investment company shares held in the subaccounts and the value of the 
    units of the subaccount involved. Therefore, there will be no change in 
    value to any Contractholder.
    
    Conclusion
    
        Applicants assert that, for the reasons summarized above, the 
    requested order approving the Substitution and related transactions 
    involving redemptions and the combination of certain separate account 
    subaccounts should be granted.
    
        For the Commission, by the Division of Investment Management, 
    pursuant to delegated authority.
    Margaret H. McFarland,
    Deputy Secretary.
    [FR Doc. 00-382 Filed 1-6-00; 8:45 am]
    BILLING CODE 8010-01-M
    
    
    

Document Information

Published:
01/07/2000
Department:
Securities and Exchange Commission
Entry Type:
Notice
Action:
Notice of application for an order of approval pursuant to Section 26(b) of the Investment Company Act of 1940 (``Act'').
Document Number:
00-382
Dates:
The application was filed on August 13, 1999, and amended and restated on December 23, 1999.
Pages:
1192-1195 (4 pages)
Docket Numbers:
Rel. No. IC-24228, File No. 812-11748
PDF File:
00-382.pdf